Use of primary breast carcinoma characteristics to predict lymph node metastases.
Cady
B
B
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001365:Axilla; D001706:Biopsy / Q000379:methods; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology* / Q000601:surgery; D002277:Carcinoma / Q000000981:diagnostic imaging / Q000473:pathology / Q000556:secondary* / Q000601:surgery; D002278:Carcinoma in Situ / Q000473:pathology / Q000556:secondary; D018270:Carcinoma, Ductal, Breast / Q000473:pathology / Q000556:secondary; D017024:Chemotherapy, Adjuvant; D003657:Decision Making; D005260:Female; D005544:Forecasting; D006801:Humans; D008197:Lymph Node Excision / Q000009:adverse effects; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging / Q000473:pathology*; D008327:Mammography; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011379:Prognosis